TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Photocure ASA ( (PHCUF) ) has issued an announcement.
Photocure ASA is set to release its third quarter 2025 financial results on October 29, 2025, with a live webcast presentation by CEO Dan Schneider and CFO Erik Dahl. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market position and investor confidence.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in providing innovative solutions for bladder cancer treatment. Their technology, which highlights cancer cells in bright pink, has significantly improved patient outcomes globally. The company is based in Oslo, Norway, and is publicly traded on the Oslo Stock Exchange.
Average Trading Volume: 50,556
Current Market Cap: NOK1.41B
See more data about PHCUF stock on TipRanks’ Stock Analysis page.